Literature DB >> 2473816

Cross sensitivity to antithyroid drugs.

A Smith1, R F Gledhill, P Jenkins.   

Abstract

Mesh:

Substances:

Year:  1989        PMID: 2473816      PMCID: PMC1836252          DOI: 10.1136/bmj.298.6682.1253-b

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  8 in total

1.  Fatal marrow aplasia after treatment with carbimazole.

Authors:  C D BURRELL
Journal:  Br Med J       Date:  1956-06-23

2.  Antithyroid activity and toxicity of mercazole and neo-mercazole.

Authors:  T R FRASER; O GARROD; M G HANNO; A JADRESIC
Journal:  J Clin Endocrinol Metab       Date:  1954-10       Impact factor: 5.958

3.  Drug-induced hepatic injury during methimazole therapy.

Authors:  J I MARTINEZ-LOPEZ; S E GREENBERG; R R KLING
Journal:  Gastroenterology       Date:  1962-07       Impact factor: 22.682

4.  A "collagen-like" syndrome associated with antithyroid therapy.

Authors:  W Hung; G P August
Journal:  J Pediatr       Date:  1973-05       Impact factor: 4.406

5.  Arthritis induced by antithyroid medication.

Authors:  K Farbman; M F Wheeler; S M Glick
Journal:  N Y State J Med       Date:  1969-03-15

Review 6.  Antithyroid drugs.

Authors:  D S Cooper
Journal:  N Engl J Med       Date:  1984-11-22       Impact factor: 91.245

7.  Recurrent agranulocytosis induced by two different antithyroid agents.

Authors:  B Chen; R Lang; Y Jutrin; M Ravid
Journal:  Med J Aust       Date:  1983-07-09       Impact factor: 7.738

8.  In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.

Authors:  J R Wall; S L Fang; T Kuroki; S H Ingbar; L E Braverman
Journal:  J Clin Endocrinol Metab       Date:  1984-05       Impact factor: 5.958

  8 in total
  1 in total

1.  Hearing loss and tinnitus with carbimazole.

Authors:  D Hill; H Whittet; H Simpson
Journal:  BMJ       Date:  1994-10-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.